In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DNA Genotek Inc.

Division of OraSure Technologies Inc.

Latest From DNA Genotek Inc.

FDA Warning Letters

QS reg violations identified at manufacturer of Oragene DX and OC-100 genetic testing devices. Six warning letters listed by FDA from Dec. 17 through Jan. 13.

Medical Device Regulation

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Deals Shaping the Medical Industry (09/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Saliva-based Testing
  • Medical Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • OraSure Technologies Inc.
  • Senior Management
  • Ian Curry, Pres. & CEO
    Patrick Walsh, CFO
    H. Chaim Birnboim, CSO
  • Contact Info
  • DNA Genotek Inc.
    Phone: (866) 813-6354
    2 Beaverbrook Rd.
    Kanata, K2K 1L1